Barritt, A. Sidney

Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018

Peery, A. F., Crockett, S. D., Murphy, C. C., Lund, J. L., Dellon, E. S., Williams, J. L., Jensen, E. T., Shaheen, N. J., Barritt, A. S., Lieber, S. R., et al. (2019) · Gastroenterology

Healthcare Policy and ManagementChronic Disease Management Strategies

Cited by 1,619

Weight loss and weight regain in usual clinical practice: results from the TARGET-NASH observational cohort

Malespin, M. H., Barritt, A. S., Watkins, S. E., Schoen, C., Tincopa, M. A., Corbin, K. D., Mospan, A. R., Munoz, B., Trinh, H. N., Weiss, L. M., et al. (2022) · Clinical Gastroenterology and Hepatology

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 75

Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study

Thomson, M. J., Serper, M., Khungar, V., Weiss, L. M., Trinh, H., Firpi-Morell, R., Roden, M., Loomba, R., Barritt, A. S., Gazis, D., et al. (2022) · Clinical Gastroenterology and Hepatology

Liver Disease Diagnosis and TreatmentLipoproteins and Cardiovascular Health

Cited by 38

Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health/substance abuse issues

Bonner, J. E., Barritt, A. S., Fried, M. W., & Evon, D. M. (2012) · Digestive Diseases and Sciences

Hepatitis C virus researchHelicobacter pylori-related gastroenterology studies

Cited by 32

Randomized Controlled Trial of a Leucine‐Metformin‐Sildenafil Combination (NS‐0200) on Weight and Metabolic Parameters

Zemel, M. B., Kolterman, O., Rinella, M., Vuppalanchi, R., Flores, O., Barritt, A. S., Siddiqui, M., & Chalasani, N. (2019) · Obesity

Pharmacology and Obesity TreatmentSirtuins and Resveratrol in Medicine

Cited by 19